SMM Feasibility Manager
Novartis
Summary
Shape where clinical trials can succeed before they even begin. As an SMM Feasibility Manager, you will turn site insights, clinical data, operational experience, and local market knowledge into recommendations that influence country and site selection for clinical trials. Working across global and local teams, you will assess feasibility, identify risks and opportunities early, and help establish realistic enrollment strategies. Your insights and ability to challenge assumptions will directly support faster study start-up, effective recruitment, and successful clinical trial delivery for patients.
Job description
Key Responsibilities
- Lead country-level feasibility assessments, translating site, patient, and operational insights into evidence-based recommendations.
- Identify and evaluate potential sites using historical performance, local expertise, competitive intelligence, and relevant data sources.
- Analyze feasibility findings to establish realistic site, patient enrollment, and study delivery commitments.
- Identify risks and opportunities early, recommending mitigation strategies to strengthen study allocation, start-up, and recruitment.
- Partner with study teams and site management/start-up colleagues to accelerate start-up and support effective recruitment planning.
- Collaborate across global and local teams to influence study strategy, feasibility decisions, and successful execution.
- Serve as the country feasibility subject-matter expert, appropriately challenging assumptions and escalating critical risks.
Essential Requirements
- Scientific degree with relevant clinical trial, clinical development, or project management experience.
- Minimum 5 years of relevant experience in clinical development, clinical operations, feasibility, study start-up, or a related pharmaceutical industry role.
- Strong analytical and critical-thinking skills to translate feasibility data and site insights into clear recommendations.
- Demonstrated ability to lead and influence effectively within complex, cross-functional and global matrix environments.
- Working knowledge of clinical trial protocols, study design, and clinical development processes, with the ability to identify operational feasibility considerations and engage appropriate subject-matter experts when needed.
- Excellent communication, negotiation, problem-solving, and conflict-resolution skills, with fluency in written and spoken English.
Requirements
- Scientific degree with relevant clinical trial, clinical development, or project management experience
- Minimum 5 years of relevant experience in clinical development, clinical operations, feasibility, study start-up, or a related pharmaceutical industry role
- Strong analytical and critical-thinking skills
- Demonstrated ability to lead and influence within complex, cross-functional and global matrix environments
- Working knowledge of clinical trial protocols, study design, and clinical development processes
- Excellent communication, negotiation, problem-solving, and conflict-resolution skills
- Fluency in written and spoken English
Benefits
- Insurance Plans
- Retirement Plans
- Wellbeing Resources
- Global Recognition Programs
- Flexible Working Options
- Hybrid Working Options
- Paid Parental Leave
- Performance-Based Bonus
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.